CAD031 Powder

Raw CAD031 Powder Basic Characters

Nootropics for Alzheimer’s disease (AD)

Nootropics, also known as cognitive enhancers or smart drugs, are substances that are believed to enhance cognitive function, memory, creativity, and overall brain performance. They can include natural compounds, synthetic drugs, or dietary supplements.[2] Nootropics are often used to support cognitive abilities such as memory, focus, and mental clarity.[4][2]

In the field of AD drug development, there are several promising candidates that have shown potential in preclinical studies. One such candidate is J-147, an experimental drug that has demonstrated effects against both AD and aging in mouse models.J-147 differs from traditional approaches to AD treatment by focusing on anti-aging effects rather than targeting amyloid plaques, a hallmark of AD pathology.

Another candidate is CMS121, a compound that acts as a fatty acid synthase inhibitor.[4] Studies have shown that CMS121 can protect against lipid peroxidation, reduce inflammation, and alleviate cognitive loss in transgenic mouse models of AD. By targeting lipid metabolism, CMS121 holds promise in addressing the dysregulated lipid processes associated with AD progression.

In addition to J-147 and CMS121, there are other AD drug candidates under investigation.CAD031 is a novel AD drug candidate with potent neuroprotective properties. It has been shown to modulate inflammation, synaptic health, and lipid metabolism.CAD031 has also demonstrated efficacy in reducing memory deficits and brain inflammation in mouse models of AD.

Overall, the development of AD drug candidates within the field of nootropics holds promise for addressing the cognitive decline and neurodegenerative processes associated with the disease. These innovative approaches offer new possibilities for improving the lives of individuals affected by AD. If you need to buy CAD031 powder for research, please select a reliable supplier online.

What is CAD031?

CAD031, also known as CAD-31.CAD-31 is a derivative of the experimental drug J147. It is a novel compound that has been developed as a potential therapeutic option for Alzheimer’s disease (AD).CAD-31 exhibits enhanced neurogenic activity over J147 in human neural precursor cells, meaning it has a stronger ability to stimulate the replication of these cells. Additionally, CAD-31 has been found to promote the utilization of free fatty acids for energy production by shifting the metabolic profile of fatty acids toward the production of ketone bodies.[3] Ketone bodies serve as an alternative source of energy in the brain when glucose levels are low.

[6][4][5]0pt” data-window-control-info=”false”>The target molecule of CAD-31 is ATP synthase, a protein found in the mitochondria. By targeting ATP synthase, CAD-31 aims to modulate mitochondrial function and energy metabolism in the brain. This modulation of energy metabolism may have potential implications for neurodegenerative diseases such as Alzheimer’s disease.

It’s important to note that CAD-31 is still under investigation and further research is needed to fully understand its efficacy, safety profile, and potential as a therapeutic intervention for AD. The supply of CAD031 powder is not big in the market.[4] Only a few of company can synthesize this material.CAD031 supplier AASRAW can supply high-purity CAD031 powder. With our independent lab and professional R&D team, the CAD031 wholesale supply is not a problem.[4]

How does CAD031 work?

CAD031 works by targeting ATP synthase, a protein found in the mitochondria of cells.ATP synthase is responsible for producing adenosine triphosphate (ATP), which is the primary energy currency of cells. By modulating the activity of ATP synthase, CAD031 aims to influence mitochondrial function and energy metabolism in the brain.

CAD031 has been shown to enhance neurogenic activity in human neural precursor cells, meaning it stimulates the replication of these cells. It also promotes the utilization of free fatty acids for energy production by shifting the metabolic profile of fatty acids toward the production of ketone bodies. Ketone bodies serve as an alternative source of energy in the brain when glucose levels are low.

By modulating energy metabolism and promoting neurogenesis, CAD031 may have potential neuroprotective effects. It is thought to help support the survival and function of neurons and potentially counteract some of the toxic events associated with neurodegenerative diseases, such as Alzheimer’s disease.

However, it’s important to note that the precise mechanisms of CAD031’s action and its full effects are still being studied and understood. Further research is needed to determine its exact mode of action and its potential as a therapeutic intervention for neurological disorders.

What are the benefits of CAD031?

CAD031, as an Alzheimer’s disease (AD) drug candidate, has shown several potential benefits based on available research:

Neuroprotective Properties: CAD031 has been found to possess potent neuroprotective properties in multiple nerve cell assays that mimic toxicities observed in the aging brain. This suggests that CAD031 has the potential to protect neurons from damage and degeneration.

Reduction of Memory Deficits: In a mouse model of AD, CAD031 has demonstrated therapeutic efficacy by reducing memory deficits. When administered to old, symptomatic AD mice, CAD031 led to a decrease in memory impairment, indicating its potential for improving cognitive function.

Decreased Brain Inflammation: CAD031 has been observed to reduce brain inflammation in AD mice. By reducing inflammatory responses in the brain, CAD031 may help mitigate the detrimental effects associated with neurodegenerative diseases.

Increased Synaptic Protein Expression: CAD031 treatment has been shown to increase the expression of synaptic proteins in the brain. Synaptic proteins are essential for maintaining healthy connections between neurons and play a crucial role in cognitive function.[4][1][3] The increase in synaptic protein expression suggests a potential for CAD031 to support synaptic health.

Effects on Fatty Acid Metabolism and Inflammation: CAD031 has been found to have a major impact on fatty acid metabolism and inflammation pathways. This suggests that CAD031 may modulate these processes, potentially leading to a favorable impact on brain health and neurodegenerative conditions.

Where to buy CAD031 powder?

In conclusion, CAD031 shows promising potential as a nootropic drug for cognitive enhancement. Further research is needed to fully understand the efficacy, long-term effects, and optimal usage of CAD031.CAD031 and similar compounds hold the potential to significantly contribute to supporting cognitive well-being and unlocking human potential. Continued research and responsible exploration will be crucial in harnessing the benefits of CAD031 for cognitive enhancement and addressing the challenges associated with cognitive decline and neurodegenerative diseases. In ensuring the safety of such substances, it is important to buy high-quality CAD031 powder from a reputable manufacturer. There are many CAD031 powders for sale online. Buying it online may be a choice. To ensure purity, please make sure they have independent test reports such as COA, HPLC, etc.[2]

Raw CAD031 Powder Testing Report-HNMR

What is HNMR and What does HNMR spectrum tell you? 

H Nuclear Magnetic Resonance (INMR)spectroscopy is an analytical chemistry technique used in quality control
and research for determining the content and purity of a sample as well as its molecular structure. For 
example, NMR can quantitatively analyze mixtures containing known compounds. For unknown compounds, NMR 
can(either be used to match against spectral libraries or to infer the basic structure directly. Once the
basic structure is known, NMR can be used to determine molecular conformation in solution as well as 
studying physical properties at the molecular level such as conformational exchange, phase changes,
solubility, and diffusion.

How to buy CAD031 Powder from AASraw?

❶To contact us by our email inquiry system, or leave your WhatsApp number to us, our customer service representative(CSR) will contact you in 12 hours.

❷To provide us with your inquired quantity and address.

❸Our CSR will provide you with the quotation, payment term, tracking number, delivery ways, and estimated arrival date(ETA).

❹Payment done and the goods will be sent out in 12 hours.

❺Goods received and give comments.

Author of this article:
Dr. Monique Hong graduated from UK Imperial College London Faculty of Medicine

Scientific Journal paper Author:
1.Trieu-Duc Vu
Laboratory of Genomics for Health and Longevity, School of Pharmacy, Kitasato University, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0373, Japan
2.Naoki Ito
Oriental Medicine Research Center, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8642, Japan
3.Devin Kepchia
Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd., La Jolla, CA 92037, USA
4.Marguerite Prior
The Salk Institute for Biological Studies, Cellular Neurobiology, La Jolla, CA, USA.
In no way does this doctor/scientist endorse or advocate the purchase, sale, or use of this product for any reason. Aasraw has no affiliation or relationship, implied or otherwise, with this physician. The purpose of citing this doctor is to acknowledge and commend the exhaustive research and development work done by the scientists working on this substance.

Reference

[1]Currais A,Huang L,Petrascheck M,Maher P,Schubert D.”A chemical biology approach to identifying molecular pathways associated with aging.”Geroscience.2021 Feb;43(1):353-365.doi: 10.1007/s11357-020-00238-5.Epub 2020 Jul 23.PMID: 32705410
[2]Prior M,Goldberg J,Chiruta C,Farrokhi C,Kopynets M,Roberts AJ,Schubert D.”Selecting for neurogenic potential as an alternative for Alzheimer’s disease drug discovery.”Alzheimers Dement.2016 Jun;12(6):678-86.doi: 10.1016/j.jalz.2016.03.016.Epub 2016 May 2.PMID: 27149904
[3]Ruth Beckervordersandforth,Chiara Rolando.”Untangling human neurogenesis to understand and counteract brain disorders.” https://doi.org/10.1016/j.coph.2019.12.002
[4]David Schubert,Antonio Currais,Joshua Goldberg,Kim Finley,Michael Petrascheck,Pamela Maher.”Untangling human neurogenesis to understand and counteract brain disorders.”https://doi.org/10.1016/j.coph.2019.12.002

Get a Bulk quotation